| ACPA | Anti-citrullinated protein antibody |
| ADA | Adalimumab |
| ADAMTS | A disintegrin and metalloproteinase with thrombospondin motifs |
| Bcl-2 | B cell lymphoma 2 |
| bDMARDs | Biological disease-modifying anti-rheumatic drugs |
| Btk | Bruton’s tyrosine kinase |
| CRP | C-reactive protein |
| csDMARDs | Conventional synthetic disease-modifying anti-rheumatic drugs |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CXCL 12 | C-X-C motif chemokine ligand 12 |
| DAS | Disease activity scale |
| DNMT1 | DNA (cytosine-5)-methyltransferase-1 |
| DMARDs | Disease-modifying anti-rheumatic drugs |
| ETA | Etanercept |
| Foxp3 | Forkhead transcription factor |
| GM-CSF | Granulated macrophage colony-stimulating factor |
| GOL | Golimumab |
| hATTR | Hereditary transthyretin amyloidosis |
| HCV | Hepatitis C virus |
| HDAC | Histone deacetylase |
| HIF1α | Hypoxia-inducible factor 1α |
| IFX | Infliximab |
| ILs | Interleukins |
| JAK | Janus kinase |
| LNA | Locked nucleic acid |
| M-CSF | Macrophage colony-stimulating factor |
| miRNA | MicroRNA |
| MMPs | Matrix metalloproteinases |
| MSC | Mesenchymal stem cells |
| MTX | Methotrexate |
| NF-κB | Nuclear factor kappa-beta |
| OA | Osteoarthritis |
| PBMC | Peripheral blood mononuclear cell |
| PI3K | Phosphoinositide 3-kinase |
| PIK3R2 | Phosphatidylinositol 3-kinase regulatory subunit 2 |
| PsA | Psoriatic arthritis |
| qRT-PCR | Quantitative reverse transcription–polymerase chain reaction |
| RA | Rheumatoid arthritis |
| RANKL | Receptor activator of nuclear factor-kappa B ligand |
| RASF | Rheumatoid arthritis synovial fibroblast |
| RF | Rheumatoid factor |
| RORC2 | Retinoic acid receptor-related orphan receptor variant 2 |
| RTX | Rituximab |
| siRNA | Small interfering RNA |
| SLE | Systemic lupus erythematosus |
| SS | Sjogren’s syndrome |
| STAT3 | Signal transducers and activators of transcription |
| Syk | Spleen tyrosine kinase |
| TCZ | Tocilizumab |
| TGF-β | Transforming growth factor-β |
| Th cells | T helper cells, helper T cells |
| TIMPs | Tissue inhibitors of metalloproteinase |
| TNF | Tumor necrosis factor |
| TLR | Toll-like receptor 2 |
| Treg cells | T regulatory cells, regulatory T cells |
| tsDMARDS | Targeted synthetic disease-modifying anti-rheumatic drugs |
| Tyk2 | Tyrosine kinase 2 |
| UC | Ulcerative colitis |
| VEGF | Vascular endothelial growth factor |
| VEGFRI | VEGF receptor I |
| Wnt | Wingless/integrated |
| XIAP | X-linked inhibitor of apoptosis protein |